BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
1150 results:

  • 1. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
    Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
    J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Ablation of kidney tumors in Patients with Substantial kidney Impairment: Current Status.
    Iguchi T; Matsui Y; Tomita K; Uka M; Umakoshi N; Kawabata T; Gobara H; Araki M; Hiraki T
    Curr Oncol Rep; 2024 May; 26(5):573-582. PubMed ID: 38625653
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas.
    Roskoski R
    Pharmacol Res; 2024 May; 203():107181. PubMed ID: 38614375
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
    Kim S; Ghiringhelli F; de la Fouchardière C; Evesque L; Smith D; Badet N; Samalin E; Lopez-Trabada Ataz D; Parzy A; Desramé J; Baba Hamed N; Buecher B; Tougeron D; Bouché O; Dahan L; Chibaudel B; El Hajbi F; Mineur L; Dubreuil O; Ben Abdelghani M; Pecout S; Bibeau F; Herfs M; Garcia ML; Meurisse A; Vernerey D; Taïeb J; Borg C
    Lancet Oncol; 2024 Apr; 25(4):518-528. PubMed ID: 38547895
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A comprehensive analysis of liver safety across zibotentan oncology trials: knowledge of the past offers new perspectives on the present.
    Fettiplace A; Matis-Mitchell S; Molodetskyi O; Söderbergh M; Oscarsson J; Lin M; Ravikiran S; Billger M; Ambery P
    Expert Opin Drug Saf; 2024 Apr; 23(4):477-486. PubMed ID: 38469902
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Prevalence and Radiologic Features of Renal Cancers Associated with
    Charbel C; Causa Andrieu PI; Soliman M; Woo S; Zheng J; Capanu M; Nikolovski I; Vargas HA; Abusamra M; Carlo MI
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230063. PubMed ID: 38456787
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DCLRE1B/Apollo germline mutations associated with renal cell carcinoma impair telomere protection.
    Bories C; Lejour T; Adolphe F; Kermasson L; Couvé S; Tanguy L; Luszczewska G; Watzky M; Poillerat V; Garnier P; Groisman R; Ferlicot S; Richard S; Saparbaev M; Revy P; Gad S; Renaud F
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167107. PubMed ID: 38430974
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hereditary Renal Cancer Syndromes.
    Yanus GA; Kuligina ES; Imyanitov EN
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
    Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
    Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
    Sato H; Ito T; Hayashi T; Kitano S; Erdjument-Bromage H; Bott MJ; Toyooka S; Zauderer M; Ladanyi M
    Oncogene; 2024 Apr; 43(15):1087-1097. PubMed ID: 38383726
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.
    Xing Z; Xu H; Ai K; Deng H; Hong Y; Deng P; Wang J; Xiong W; Li Z; Zhu L; Li Y
    Ann Surg Oncol; 2024 May; 31(5):3531-3543. PubMed ID: 38329657
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel model for predicting deep-seated candidiasis due to Candida glabrata among cancer patients: A 6-year study in a cancer center of China.
    Li D; Wang L; Zhao Z; Bai C; Li X
    Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38318635
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Predictive Power of Bosniak 3 and 4 Cystic Renal Lesion Categorization Using Contrast-Enhanced Ultrasound.
    Járay Á; Farkas PI; Semjén D; Botz B
    J Ultrasound Med; 2024 May; 43(5):933-949. PubMed ID: 38284141
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
    Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
    Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 16. Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis.
    Rosellini M; Mollica V; Marchetti A; Coluccelli S; Giunchi F; Tassinari E; Ricci C; Fiorentino M; Tallini G; De Biase D; Massari F
    Pathol Res Pract; 2024 Feb; 254():155142. PubMed ID: 38277752
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Renal Function After CT-Guided Cryoablation of Small Renal Tumours in Patients with Solitary kidney: An Analysis of European Multinational Prospective EuRECA Registry.
    Pietersen PI; Stougaard S; Keeley FX; Lagerveld B; Breen D; King A; Nielsen TK; van Strijen M; Garnon J; Alcorn D; de Kerviler E; Zondervan P; Wah TM; Junker T; Graumann O
    Cardiovasc Intervent Radiol; 2024 May; 47(5):583-589. PubMed ID: 38273129
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for kidney Transplant Recipients With Advanced Cutaneous Cancers.
    Schenk KM; Deutsch JS; Chandra S; Davar D; Eroglu Z; Khushalani NI; Luke JJ; Ott PA; Sosman JA; Aggarwal V; Schollenberger MD; Sharfman WH; Bibee KP; Scott JF; Loss MJ; Wang H; Qi H; Sharon E; Streicher H; Chen HX; Woodward RN; Bagnasco SM; Taube JM; Topalian SL; Brennan DC; Lipson EJ
    J Clin Oncol; 2024 Mar; 42(9):1011-1020. PubMed ID: 38252910
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cationic and amphiphilic peptide-based hydrogels with dual activities as anticancer and antibacterial agents.
    Mondal T; Chatterjee A; Hansda B; Mondal B; Sen P; Banerjee A
    Soft Matter; 2024 Feb; 20(6):1236-1244. PubMed ID: 38230549
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 58.